Viracta Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
DEFA14A: Viracta Therapeutics Sets Date for Annual Stockholders Meeting, Seeks Approval on Key Proposals
Viracta Therapeutics will hold its annual stockholders meeting on June 18, 2024, seeking votes on director elections, executive compensation, and auditor ratification.
Viracta Therapeutics will hold its 2024 annual meeting of stockholders virtually on June 18, 2024, to vote on director elections, executive compensation, and auditor ratification.